My apologies, it wasn't meant to be strictly a reply to your post.
But if you read the reports of 2015 & 2016 the issue of financing the growth is very important (and it is growing fast with the aging population and population increase as stated in the reports). Whether it is through RAD or DAP it is still a benefit to the providers. It is either an interest free loan as in RAD or regular cash in the bank payments as in DAP I am agnostic.
Bottom line - not having a viable long term private sector financing mechanism is not an option.
The AFR is focusing on a subject matter which is immaterial. If need be (I don't think so),
a $50m placement about 1 for 10 can be raised without a sweat.
EHE Price at posting:
$2.71 Sentiment: Buy Disclosure: Held